Mark Butler's decision to 'respectfully' write to the PBAC to ask that it reconsider its previous advice on the GSK therapies was an unnecessary but subtle and entirely legitimate exercise of this ministerial power over PBS decision-making. …
The minister did not need the committee's advice to reverse these changes
May 15, 2023 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Nobody can possibly sustain an argument this is not a price negotiation
August 15, 2025 - - Latest News -
When it comes to PBAC outcomes, it's all in the language, about pricing
August 15, 2025 - - Latest News -
Interim report calls for prevention focus to boost the nation's productivity
August 14, 2025 - - Latest News -
Just because the system involves humans, it does not make it human
August 14, 2025 - - Latest News -
Australian company Mirugen secures backing to process cell technology
August 13, 2025 - - Latest News -
AccessCR’s awards celebrate partnerships between lived experience and science
August 13, 2025 - - Latest News -
Firebrick says Nasodine COVID-19 patent accepted in Europe
August 13, 2025 - - Australian Biotech